Cite
HARVARD Citation
Reck, M. et al. (n.d.). Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Lung cancer. 90 (2), pp. 267-273. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Reck, M. et al. (n.d.). Anti-angiogenic-specific adverse events in patients with non-small cell lung cancer treated with nintedanib and docetaxel. Lung cancer. 90 (2), pp. 267-273. [Online].